Gabapentin Drug Review: PTCB Exam Must-Know

Gabapentin Overview for Pharmacy Technicians

Gabapentin has become one of the most widely prescribed medications in the United States, used for a range of neurological and pain conditions. Its increasing use and recent scheduling changes in some states make it an important drug for PTCB exam preparation.

Brand Name and Classification

Gabapentin is sold under the brand name Neurontin. An extended-release formulation is available as Gralise, and an enacarbil prodrug formulation is marketed as Horizant. Gabapentin is classified as an anticonvulsant/antiepileptic, though it is more commonly prescribed for pain than for seizures.

Mechanism of Action

Despite being structurally related to GABA (gamma-aminobutyric acid), gabapentin does not bind to GABA receptors. Its primary mechanism involves binding to the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release. This mechanism underlies its effectiveness in both seizure control and neuropathic pain management.

Common Indications

Postherpetic neuralgia: FDA-approved for nerve pain following shingles
Epilepsy: Adjunctive therapy for partial seizures
Neuropathic pain: Widely used off-label for diabetic neuropathy and other nerve pain
Restless legs syndrome: Horizant formulation is FDA-approved for RLS
Fibromyalgia: Off-label use for chronic pain

Dosing Information

Gabapentin is available in 100 mg, 300 mg, 400 mg, 600 mg, and 800 mg capsules and tablets, plus a 250 mg/5 mL oral solution. Dosing varies by indication:

Neuropathic pain: Start at 300 mg at bedtime, titrate to 300 mg three times daily, maximum 3,600 mg/day
Seizures: 300 to 600 mg three times daily

Gabapentin requires renal dose adjustment because it is eliminated unchanged by the kidneys. This is a testable PTCB concept.

Side Effects

Somnolence and dizziness: Most common, especially during dose titration
Peripheral edema: Swelling of extremities
Weight gain: Reported with chronic use
Ataxia: Loss of coordination, particularly in elderly patients
Blurred vision: Usually transient

Scheduling and Abuse Potential

Gabapentin is not federally scheduled, but several states have classified it as a Schedule V controlled substance due to growing concerns about misuse and diversion. Some states require gabapentin to be reported to the Prescription Drug Monitoring Program (PDMP). Pharmacy technicians should be aware of their state's specific regulations.

PTCB Exam Tips

Remember: gabapentin is brand Neurontin, it requires renal dose adjustment, the main side effects are drowsiness and dizziness, and some states have scheduled it as a controlled substance. Know that the different formulations (Neurontin, Gralise, Horizant) are not interchangeable.

Test your drug knowledge at PTCBprep flashcards and practice exams.